R. Otte

Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.

R. Fimmers, H. Biersack, H. Bender, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Redifferentiation therapy with retinoic acid in follicular thyroid cancer.

E. Pakos, H. Biersack, H. Bender, 1998, Journal of Nuclear Medicine.

Course of Time and Extent of The Thyroid Volume Reduction after Radioiodine Therapy in Graves Disease and Autonomous Goiter

H. Schicha, B. Dederichs, R. Otte, 1997 .

Cytofluorographic Analysis of Pokeweed Mitogen‐stimulated Human Peripheral Blood Cells in Culture

S. Wormsley, R. Otte, J. W. Hollingsworth, 1983, Journal of the American Geriatrics Society.

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-d-Phe1-octreotide

M. Béhé, H. Biersack, H. Bender, 2000, European Journal of Nuclear Medicine.

Immunodeficiency and lymphocyte ecto-5′-nucleotidase activity in the elderly: A comparison of the effect of a trace mineral supplement (1 USRDA) with high zinc (6.7 X USRDA)

G. Boss, L. Strause, P. Saltman, 1987 .

[Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter].

H. Schicha, B. Dederichs, R. Otte, 1996, Nuklearmedizin. Nuclear medicine.